November 7, 2018

Symphogen Selects TransPerfect’s Trial Interactive eTMF Technology and Services

NEW YORK–(BUSINESS WIRE)–TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Symphogen has selected TransPerfect’s Trial Interactive eTMF and supporting TMF services to centralize and streamline operations for current and future studies. Based in Copenhagen, Denmark, Symphogen is a private, late-stage clinical oncology-focused company with a novel and differentia


Leave Comment


Your Name *
Your Email *
Your Website

Comment *